Take 5 with Dan Blake – 5 Minutes, 5 Questions on the World of Clinical Mass Spec by SCIEX Community | Jan 15, 2019 | Blogs, ClinicalWe would like to formally (or informally) introduce the new SCIEX Clinical Diagnostics blog series entitled, Take 5. Every couple of months we will ask a member of our team to answer five questions and share their responses in a format you can read in five minutes. We...
The Technology Behind Safe, Legal Cannabis by SCIEX Community | Jan 14, 2019 | Blogs, Food / BeverageThe Third in a Three-Part Series Part 1: Cannabis is Legal in Canada – How Did We Get Here? Part 2: Canada’s Focus on Cannabis Quality and Safety Intensifies Welcome to the third in a series of blogs from the cannabis team at SCIEX, designed to bring you...
What is Multi Attribute Methodology (MAM)? by SCIEX Community | Jan 8, 2019 | Biopharma, BlogsQ&A with Sean McCarthy Global Market Manager, Biologics, SCIEX MAM is an acronym for Multiple Attribute Method. In short, MAM is a method which may be applied for characterization of a biotherapeutic to understand its sequence, identify liabilities, identify...
New Methods for N-Glycan Sequencing Provide Structural Information in as Little as 1 Hour by SCIEX Community | Jan 2, 2019 | Biopharma, BlogsAs interest in N-glycan analysis grows within the biopharma industry, innovation continues allowing analyses to be done in less time with fewer and less tedious, sample preparation steps. One of these recent innovations was the release of the SCIEX Fast Glycan...
When Chiral Separation Turns Tricky: The Story Behind CESI-MS in Forensic Chiral Analysis by SCIEX Community | Jan 1, 2019 | Blogs, ForensicAgainst a backdrop of rapid growth, chirality plays a major role in the synthesis of drugs in both pharmaceutical and illicit drug development. In fact, more than half of the drugs currently in use are chiral compounds, available as either racemates or pure...